Advisory Committee

Main Content

The Advisory Committee is a multi-stakeholder group of experts representing the range of CIBMTR’s activities. The major responsibility of this committee is to advise CIBMTR’s leadership on scientific direction, policy, and priority use of resources in the context of the larger cellular therapy environment.

Responsibilities

Advisory Committee Chair:

Leads the Advisory Committee meetings throughout their term including in-person at the annual Tandem Meetings
Agrees and approves meeting agendas and minutes with CIBMTR leadership
Reviews committee leadership Conflict of Interest disclosures
Approves the appointment of CIBMTR representatives, including a Program Chair, to the Tandem Meetings Scientific Organizing Committee
Performs functions on behalf of CIBMTR at the annual Tandem Meetings including, but not limited to; as part of the Joint Senior Leadership Team, participation on monthly planning calls, participation in the Scientific Organizing Committee, introduction of certain speakers, including the Mortimer M. Bortin lecturer and presentation of awards.
Contribute materials to CIBMTR newsletters or other communications
Chairs any executive sessions of the Advisory Committee that are convened
Participates in the annual onboarding of new Advisory Committee members
Fulfills all other roles of the Advisory Committee as needed
Attend an onboarding prior to their first year on the Advisory Committee
Attend at least 75 percent of the annual Advisory Committee meetings

Advisory Committee Chair-Elect:

Replaces the chair to lead meetings in the unusual situation that the chair is unavailable or has declared a conflict of interest
Moves to the chair role early in the event that the chair should unexpectedly leave the position
Approves the appointment of CIBMTR representatives, including a Program Chair, to the Tandem Meetings Scientific Organizing Committee
Participates as able in any executive sessions of the Advisory Committee that are convened
Participates in annual onboarding of new Advisory Committee members
Fulfills all other roles of the Advisory Committee as needed

Advisory Committee Past Chair:

Supports the incoming chair in their role
Participates as able in any executive sessions of the Advisory Committee that are convened
Fulfills all other roles of the Advisory Committee as needed

Advisory Committee Member:

Agrees and approves meeting minutes
May be asked to contribute materials to CIBMTR newsletters or other communications
May participate in the annual onboarding of new Advisory Committee members
Fulfills all other roles of the Advisory Committee as needed
Attend an onboarding prior to their first year on the Advisory Committee
Attend at least 75 percent of the annual Advisory Committee meetings

Advisory Committee Member representing a sub-committee (Consumer Advocacy Committee, Nominating Committee):

Represents their sub-committee on the Advisory Committee including raising topics of interest to the committee
Fulfills all other roles of the Advisory Committee as needed

Membership

Individuals appointed to the Advisory Committee should represent stakeholders broadly including:
Expertise in adult and pediatric clinical care;
Expertise in hematopoietic cell transplantation and cellular and gene therapies;
Expertise in donor selection and graft collection and manipulation;
Representation of US and non-US centers;
Familiarity with CIBMTR operations; and
Representation of patient, family, and donor interests. Members to represent donor centers and collection centers are appointed by the Chief Scientific Director, CIBMTR NMDP

Meetings

In-person Advisory Committee meetings are conducted once annually during the Tandem Meetings of ASTCT & CIBMTR. Additional meetings take place by conference call at least two times annually. for review of the research agenda. Meetings are open to the public and federal representatives, except on rare occasions when deliberations pose a conflict of interest (such as in-center confidentiality). Ad hoc task forces meet by teleconference as needed to address specific issues.

Chair

Michael Verneris, MD, University of Colorado - Children's Hospital, Aurora, CO

Chair Elect

Sumithira Vasu, MBBS, MD, Ohio State Medical Center, James Cancer Center, Columbus, OH

At Large Members

Andrew Artz, MD, MS, City of Hope, Duarte, CA
Ami Bhatt, MD, PhD, Stanford Health Care, Stanford University School of Medicine, Stanford, CA
Courtney Fitzhugh, MD, National Heart Lung and Blood Institute – NIH Bethesda, MD
Mary Flowers, MD, Fred Hutchinson Cancer Center, Seattle, WA
Leo Luznik, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Shannon Maude, MD, PhD, Children’s Hospital of Philadelphia, PA
Sung-Yun Pai, MD, National Cancer Institute – NIH, Bethesda, MD
Rayne Rouce, MD, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX
Kirsten Williams, MD, Emory University Hospital, Atlanta, GA

International Members

Yoshiko Atsuta, MD, PhD, Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
Rafael Duarte, MD, PhD, Clinica Puerta de Hierro, Barcelona, Spain
David Gómez-Almaguer, MD, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico
Tracey O'Brien, MBA, LLM, MBChB, BSc, Kid's Cancer Center, Sydney Children's Hospital, Sydney, Australia
Jakob Passweg, MD, MS, University Hospital Basel, Basel, Switzerland
Vanderson Rocha, MD, PhD, CTMO-HCFMUSP, São Paolo, Brazil
Guillermo Ruiz-Argüelles, MD, MACP, Clinica Ruiz de Puebla, Puebla, Mexico
Hélène Schoemans, MD, University Hospital Gasthuisberg, Leuven, Belgium
Luca Vago, MD, PhD, Ospedale San Raffaele, Milano, Italy

Committee Chair Members

Adoptive Cellular Therapies Stakeholders Council Chair: Amanda Olson, MD, M.D. Anderson Cancer Center, Houston, TX
Consumer Advocacy Committee Co-Chairs:
- Brandon Nuechterlein, Aurora, CO
- Robert Lisac, Jacksonville, FL
Nominating Committee Chair: Marcos de Lima, MD, Ohio State Medical Center, James Cancer Center, Cleveland, OH

Other Appointed Members

Bioethicist: Gregory Abel, MD, MPH, Dana Farber Cancer Institute, Boston, MA
Business Representative: Jeff Chell, MD, NMDP, Minneapolis, MN
Collection Center Representative: Huy Pham, MD, MPH, NMDP, Seattle, WA
Cord Blood Bank Representative: Wouter Van’t Hof, PhD, Cleveland Cord Blood Center, Warrensville Heights, OH

Ex Officio Voting Members

ASTCT President: Corey Cutler, MD, MPH
ONR Representative: TBD
MCW/NCI Project Officer: Lori Henderson, PhD
MCW/NHLBI Project Officers:
- Nancy DiFronzo, PhD
- Nahed El Kassar, MD, PhD
MCW/NIAID Project Officer: Linda Griffith, MD, PhD

Ex Officio Non-Voting Members

Chief Scientific Director, CIBMTR MCW; Co-PI of the CIBMTR Infrastructure U24, CIBMTR MCW: Bronwen Shaw, MD, PhD
Chief Scientific Director, CIBMTR NMDP; Senior Vice President, Health Equity, NMDP: Jeffery Auletta, MD
Chief Statistical Director, CIBMTR MCW: Kwang Woo Ahn, PhD
Executive Scientific Director, Policy and Governance, CIBMTR MCW: Patricia Steinert, PhD, MBA
Vice President, CIBMTR and Clinical Services, NMDP: Mary Hengen, MBA
Senior Scientific Director and Principal Investigator of the SCTOD, CIBMTR MCW: J. Douglas Rizzo, MD, MS
Vice President of Research and Senior Scientific Director, CIBMTR NMDP: Steve Spellman, MBS
Senior Scientific Director, CIBMTR MCW; Co-PI of the CIBMTR Infrastructure U24, CIBMTR MCW: Marcelo Pasquini, MD, MS
Chief Medical Officer, NMDP; Senior Scientific Director, CIBMTR NMDP: Steven Devine, MD
Chief Executive Officer, NMDP: Amy Ronneberg
Scientific Director Emeritus, CIBMTR MCW: Mary M. Horowitz, MD, MS
Director, Strategic Programs, NMDP: Meggan McCann, MPH
HRSA Contracting Officer Representatives:
- Nawraz Shawir, MBBS
- Marilyn Levi, MD